Recalls from Teva Pharmaceuticals USA, Inc

• Teva Metoclopramide Tablets (opens in a new tab)
  Moderate risk, FDA, Oct 13, 2026, Foreign object
• Teva Trazodone Hydrochloride Tablets (opens in a new tab)
  Moderate risk, FDA, Sep 2, 2026, Foreign object
• Teva Octreotide Acetate for Injectable Suspension (opens in a new tab)
  Moderate risk, FDA, May 5, 2026, Sterility problem
• Teva Claravis Isotretinoin Capsules (opens in a new tab)
  Moderate risk, FDA, Apr 17, 2026, Drug impurity
• Actavis Clonidine Transdermal System (opens in a new tab)
  Moderate risk, FDA, Apr 13, 2026, Manufacturing problem

Data: Recall Canary (opens in a new tab)